Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of AZD0914 assessing safety, tolerability, and pharmacokinetics in gonorrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonorrhea

Drugs mentioned

• AZD0914

Snippet

Sponsor: AstraZeneca | Conditions: Gonococcal (GC) Infection | Phase 1 | Status: COMPLETED